Clinical Trials on Hormone-sensitive Metastatic Breast Cancer in France
Total 2392 results
-
MedImmune LLCCompletedHormone-sensitive, HER-2 Negative Metastatic Breast CancerSpain, United States, Belgium, France, United Kingdom, Canada, Israel, Germany, Hungary, Poland, Bahamas
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedGIST Metastatic Cancer | Breast Metastatic Cancer | Kidney Metastatic Cancer | Colon Metastatic Cancer | Rectal Metastatic CancerFrance
-
Institut de Cancérologie de la LoireSaint-Louis Hospital, Paris, France; Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Metastatic Breast Cancer | Metastatic Head and Neck CancerFrance
-
Institut CurieUnknownDuctal Infiltrating Metastatic Breast Cancer | Hormone-receptors Positive Breast CancerFrance
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
University of California, IrvineRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
Institut Cancerologie de l'OuestTerminatedMetastatic Breast Cancer | Positive Hormonal ReceptorsFrance
-
Centre Oscar LambretRecruitingOvarian Cancer | Hormone-resistant Prostate Cancer | Circulating Tumor Cell | HER2-positive Metastatic Breast CancerFrance
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.RecruitingMetastatic Breast CancerFrance
-
Centre Henri BecquerelCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Centre Jean PerrinTerminated
-
Centre Georges Francois LeclercSanofi; GlaxoSmithKlineCompletedMetastatic Breast CancerFrance
-
Assistance Publique - Hôpitaux de ParisCompletedMetastatic Breast CancerFrance
-
ARCAGY/ GINECO GROUPNovartisCompletedBreast Neoplasms | mTor ProteinFrance
-
Janssen-Cilag Ltd.RecruitingMetastatic Hormone-sensitive Prostate CancerFrance, Germany, Spain, Greece, Austria, United Kingdom
-
Institut Claudius RegaudFondation Toulouse Cancer SantéNot yet recruitingMetastatic Breast CancerFrance
-
ARCAGY/ GINECO GROUPCompleted
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Institut CurieRecruitingHER2-negative Metastatic Breast CancerFrance
-
UNICANCERGilead SciencesRecruitingMetastatic Breast Cancer | Triple Negative Breast CancerFrance
-
Centre Francois BaclesseActive, not recruitingBreast Cancer | Metastatic Breast CancerFrance
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
Institut Paoli-CalmettesNovartis PharmaceuticalsRecruitingAdvanced or Metastatic Breast Cancer (BC)France
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
ARCAGY/ GINECO GROUPTerminatedFirst Line Metastatic Breast CancerFrance
-
Centre Hospitalier Universitaire de BesanconNational Cancer Institute, FranceCompletedGastrointestinal Metastatic CancerFrance
-
Hospices Civils de LyonRecruitingMetastatic Breast Cancer | Metastatic NSCLC | Metastases to BoneFrance
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Centre Jean PerrinTerminatedNon Metastatic Breast CancerFrance
-
Centre Antoine LacassagneThuasneRecruitingNon-metastatic Breast CancerFrance
-
Institut Cancerologie de l'OuestCompletedNon Metastatic Breast CancerFrance
-
Hospices Civils de LyonRecruitingBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cancer MetastaticFrance
-
UNICANCERSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisFrance
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
Institut Cancerologie de l'OuestCompletedToxicity | Pancreatic Metastatic CancerFrance
-
Centre Jean PerrinTerminated
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Institut CurieRain Oncology IncTerminatedAdvanced or Metastatic Breast CancerFrance
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Institut CurieTerminated
-
UNICANCERCompletedMetastatic CancersFrance
-
Immutep S.A.S.UmanisCompleted
-
Centre Hospitalier Universitaire de BesanconCompletedMetastatic Anal Canal Cancer | Human PapillomavirusFrance
-
ZionexaGE Healthcare; Simbec-Orion Group; KeosysRecruitingMetastatic Breast CancerFrance
-
UNICANCERRecruiting
-
UNICANCERRecruitingBreast Cancer Nos Metastatic RecurrentFrance
-
UNICANCERMinistry of Health, FranceActive, not recruitingPrimary Non-metastatic Breast Cancer | Who Remain Disease-freeFrance
-
Centre Leon BerardCompleted